Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesPayablesPreferred SharesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Us Nuclear (UCLE) Cash & Equivalents (2017 - 2025)

Us Nuclear's Cash & Equivalents history spans 9 years, with the latest figure at $75907.0 for Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 138.87% year-over-year to $75907.0; the TTM value through Sep 2025 reached $75907.0, up 138.87%, while the annual FY2024 figure was $130840.0, 14.39% down from the prior year.
  • Cash & Equivalents for Q3 2025 was $75907.0 at Us Nuclear, up from $46285.0 in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $420907.0 in Q2 2022 and bottomed at $31778.0 in Q3 2024.
  • The 5-year median for Cash & Equivalents is $132191.0 (2024), against an average of $160789.9.
  • The largest annual shift saw Cash & Equivalents surged 225.31% in 2023 before it tumbled 82.8% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $246317.0 in 2021, then plummeted by 48.8% to $126109.0 in 2022, then increased by 21.2% to $152840.0 in 2023, then fell by 14.39% to $130840.0 in 2024, then plummeted by 41.98% to $75907.0 in 2025.
  • Per Business Quant, the three most recent readings for UCLE's Cash & Equivalents are $75907.0 (Q3 2025), $46285.0 (Q2 2025), and $68489.0 (Q1 2025).